Javascript must be enabled to continue!
Consultancy in ‘failing schools’: Emerging issues
View through CrossRef
External consultancy in schools by those who do not belong to the teaching staff has always been an important factor in school development. Such consulting goes hand in hand with the idea that internal school development processes and their results can be influenced positively by external experts. This is even more so for failing schools – that is, those that are revealed to have serious quality deficiencies by the school inspection. (The term failing schools is used in this article as shorthand; the actual terminology, and the underlying thinking, varies between education systems.) This article considers how school development consultancy is exercised by external experts in schools that have been classified as failing. It draws on empirical findings in part from a research project with schools found to have serious deficiencies in the first round of school inspections in the German federal state of Lower Saxony. Our research reveals that the framework conditions under which the outcomes of the inspections are processed at failing schools (in particular, the follow-up inspection) influence the activities in the school in such a way that a specific type of consultancy and/or a specific procedure by the advisers becomes attractive for the schools. This sometimes works against a closer examination of contents, strategies and instruments in school development – although the consultancy contracts advise this. This article, therefore, deals with how external consultancy for school development would have to be designed conceptually in order to effectively support the development activities at failing schools.
Title: Consultancy in ‘failing schools’: Emerging issues
Description:
External consultancy in schools by those who do not belong to the teaching staff has always been an important factor in school development.
Such consulting goes hand in hand with the idea that internal school development processes and their results can be influenced positively by external experts.
This is even more so for failing schools – that is, those that are revealed to have serious quality deficiencies by the school inspection.
(The term failing schools is used in this article as shorthand; the actual terminology, and the underlying thinking, varies between education systems.
) This article considers how school development consultancy is exercised by external experts in schools that have been classified as failing.
It draws on empirical findings in part from a research project with schools found to have serious deficiencies in the first round of school inspections in the German federal state of Lower Saxony.
Our research reveals that the framework conditions under which the outcomes of the inspections are processed at failing schools (in particular, the follow-up inspection) influence the activities in the school in such a way that a specific type of consultancy and/or a specific procedure by the advisers becomes attractive for the schools.
This sometimes works against a closer examination of contents, strategies and instruments in school development – although the consultancy contracts advise this.
This article, therefore, deals with how external consultancy for school development would have to be designed conceptually in order to effectively support the development activities at failing schools.
Related Results
Development and Exploitation of a Fully Human and Modular Organotypic Bone Marrow Niche Model to Study the Role of Stroma-Produced Factors in Human MDS
Development and Exploitation of a Fully Human and Modular Organotypic Bone Marrow Niche Model to Study the Role of Stroma-Produced Factors in Human MDS
Background: Myelodysplastic syndromes (MDS) are a heterogenous group of stem cell driven disorders primarily affecting the elderly and characterized by inefficient production of ma...
Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma
Nfkbiz 3′ UTR Mutations Confer Selective Growth Advantage and Affect Drug Response in Diffuse Large B-Cell Lymphoma
Introduction: The activated B-cell-like (ABC) molecular subgroup of diffuse large B-cell lymphoma (DLBCL) is characterized by activation of NF-κB signaling and increased mortality....
Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study
Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study
Abstract
Background: The phase 3 GIMEMA-MMY-3006 study comparing bortezomib-thalidomide-dexamethasone (VTD) vs. thalidomide-dexamethasone (TD) as induction therapy b...
Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center
Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center
Abstract
INTRODUCTION: Mutation of FLT3, a tyrosine kinase receptor, is one of the most common molecular alterations in AML. In 2017, the FDA approved midostaurin fo...
Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial
Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial
Background: Despite optimal prophylactic platelet (plt) transfusion therapy for severe thrombocytopenia in patients undergoing treatment for hematologic malignancy, WHO Grade 2 or ...
The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
The Development of a Precision Medicine Platform to Overcome Ibrutinib Resistance in Mantle Cell Lymphoma
Background: While mantle cell lymphoma (MCL) initially responds to frontline therapies, this aggressive B-cell malignancy typically relapses or becomes resistant to treatment. Desp...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Low-Dose Immune Tolerance Induction for Hemophilia a Children with Poor-Risk High-Titer Inhibitors
Low-Dose Immune Tolerance Induction for Hemophilia a Children with Poor-Risk High-Titer Inhibitors
Background:
Low-dose immune tolerance induction (ITI) +/- immunosuppression as a practical ITI strategy in China showed a relatively satisfactory success rate and ec...

